Literature DB >> 33664715

Fecal Carriage and Genetic Characterization of CTX-M-1/9/1-Producing Escherichia coli From Healthy Humans in Hangzhou, China.

Jiawei Chen1, Sheng Chen2, Yin Jiang3, Rong Zhang1, Jiachang Cai1.   

Abstract

CTX-M-199, a novel chimeric β-lactamase which mediated resistance to sulbactam and tazobactam, was recently identified in Hangzhou, China. This study investigated the prevalence of fecal carriage of bacteria producing CTX-M-199 and other CTX-M-1/9/1-type enzymes among healthy individuals and characterized the genetic features of bla CTX-M-1/9/1-bearing mobile elements. A total of 74 Enterobacterales strains carrying various bla CTX-M-1/9/1 genes, including bla CTX-M-64 (n = 40, carriage rate of 0.74%), bla CTX-M-199 (n = 23, 0.40%), bla CTX-M-123 (n = 5, 0.10%), novel bla CTX-M-153 (n = 5, 0.10%), and bla CT X-M-132 (n = 2, 0.04%), were isolated from 68 out of 5,000 (1.36%) fecal samples of healthy adults in Hangzhou City. Phylogenetic analysis based on whole-genome sequencing data showed that 72 bla CTX-M-1/9/1-bearing Escherichia coli isolates were clustered into four major clades, three of which included CTX-M-199 producers. Sixty out of 75 bla CTX-M-1/9/1 genes were located on plasmids belonging to four Inc types: IncI2, IncI1, IncFIB, and IncHI2. The bla CTX-M-199 genes were harbored by three of the four types of plasmids except for IncHI2. All these bla CTX-M-1/9/1 genes were carried on an ISEcp1-mediated transposition unit. In conclusion, human fecal carriage of bla CTX-M-1/9/1 was low in healthy populations of China. The ISEcp1 was commonly associated with bla CTX-M-1/9/1 and may mediate its transmission on various mobile elements. Our findings provide insights into the dissemination and the development of further measures for the control of pathogens producing CTX-M-1/9/1-type enzymes.
Copyright © 2021 Chen, Chen, Jiang, Zhang and Cai.

Entities:  

Keywords:  CTX-M-199; fecal colonization; hybrid; inhibitor resistance; plasmid replicon

Year:  2021        PMID: 33664715      PMCID: PMC7921147          DOI: 10.3389/fmicb.2021.616687

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  38 in total

Review 1.  The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens.

Authors:  Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2004-06-25       Impact factor: 9.079

Review 2.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

3.  blaCTX-M-1/9/1 Hybrid Genes May Have Been Generated from blaCTX-M-15 on an IncI2 Plasmid.

Authors:  Lanping Liu; Dandan He; Luchao Lv; Wuling Liu; Xiaojie Chen; Zhenling Zeng; Sally R Partridge; Jian-Hua Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

4.  Genetic and Functional Characterization of blaCTX-M-199, a Novel Tazobactam and Sulbactam Resistance-Encoding Gene Located in a Conjugative mcr-1-Bearing IncI2 Plasmid.

Authors:  Jiachang Cai; Qipeng Cheng; Yingbo Shen; Danxia Gu; Ying Fang; Edward Wai-Chi Chan; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

5.  Escherichia coli ST1421 harbouring the hybrid extended-spectrum β-lactamase CTX-M-64 from a German patient.

Authors:  Yvonne Pfeifer; Guido Werner; Barbara Körber-Irrgang; Daniel Jonas; Michael Kresken
Journal:  J Glob Antimicrob Resist       Date:  2018-02-08       Impact factor: 4.035

6.  Spread of CTX-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates of Epidemic Clone B2-O25-ST131 Among Dogs and Cats in Japan.

Authors:  Kumiko Kawamura; Tae Sugawara; Nao Matsuo; Kengo Hayashi; Chihiro Norizuki; Kiyoko Tamai; Takaaki Kondo; Yoshichika Arakawa
Journal:  Microb Drug Resist       Date:  2017-04-05       Impact factor: 3.431

7.  CTX-M-123, a novel hybrid of the CTX-M-1 and CTX-M-9 Group β-lactamases recovered from Escherichia coli isolates in China.

Authors:  Dandan He; Sally R Partridge; Jianzhong Shen; Zhenling Zeng; Lanping Liu; Lili Rao; Luchao Lv; Jian-Hua Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

8.  The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes.

Authors:  Todd J Treangen; Brian D Ondov; Sergey Koren; Adam M Phillippy
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees.

Authors:  Ivica Letunic; Peer Bork
Journal:  Nucleic Acids Res       Date:  2016-04-19       Impact factor: 16.971

10.  Detection and characterization of a clinical Escherichia coli ST3204 strain coproducing NDM-16 and MCR-1.

Authors:  Xi Li; Xinli Mu; Ping Zhang; Dongdong Zhao; Jingshu Ji; Jingjing Quan; Yongze Zhu; Yunsong Yu
Journal:  Infect Drug Resist       Date:  2018-08-15       Impact factor: 4.003

View more
  1 in total

1.  Nasal carriage of CTX-M-55-producing Escherichia coli ST8369 in a healthy cohort in the city of Yangzhou, China.

Authors:  Zhen-Yu Wang; Yue Jiang; Yi-Qiao Shao; Heng-Fan Lu; Meng-Jun Lu; Xinan Jiao; Qiu-Chun Li; Jing Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-03       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.